30 results about "Preventing initiation" patented technology

A method of preventing initiation of an explosive device. The method comprises substantially encasing an explosive device with a conductive foam. The explosive device is configured to be initiated by an electromagnetic radiation signal, such as that emitted by a transmitter of a wireless door bell device. Deactivated explosive devices are also disclosed.

A mobile station for transferring delay-sensitive data to a wireless communications network is provided with an uplink resource release controller that selectively inhibits release of an uplink resource in order to meet requirements of a delay-sensitive data application, such as a VoIP or streaming application. In one embodiment, the uplink resource release controller causes dummy blocks to be written to a data buffer to prevent initiation of a countdown process. By intelligently controlling resource release, delay-sensitive data may be transmitted in a more reliable fashion, thereby increasing application performance.

A method of producing a propellant material element, such as an electrically-operated propellant material, includes extruding a propellant material through a heated nozzle. The nozzle may be heated to a temperature that is above the boiling point of a solvent that is part of the propellant material, yet is below a decomposition temperature of the propellant material. This allows some of the solvent to be driven off during the extruding process, while still preventing initiation of an energy-creating reaction within the material. The heating of the material in the extruding process, and especially the heating of the nozzle that the material is extruded through, may be controlled to remove an amount of solvent that results in the extruded material having desirable properties.

The invention provides methods for treating inflammatory diseases by administering to the subject an effective amount of an agent that provides alpha B-crystallin activity, where the dose is effective to suppress or prevent initiation, progression, or relapses of disease, including the progression of established disease. In some embodiments, the methods of the invention comprise administering to a subject having a pre-existing inflammatory disease condition, an effective amount of alpha B-crystallin protein, to suppress or prevent relapses of the disease.

The invention provides methods for treating inflammatory diseases by administering to the subject an effective amount of an agent that provides alpha B-crystallin activity, where the dose is effective to suppress or prevent initiation, progression, or relapses of disease, including the progression of established disease. In some embodiments, the methods of the invention comprise administering to a subject having a pre-existing inflammatory disease condition, an effective amount of alpha B-crystallin protein, to suppress or prevent relapses of the disease.

A method for protecting Ethernet data packets transmitted over SDH / SONET traffic in a ring-like optical network formed by a number of nodes, the method includes utilizing MS-SPRING / BLSR system for SDH / SONET traffic protection and, in case of one or more network failures that result in at least one isolated node in the network, the method comprises preventing initiation of a squelching algorithm of the MS-SPRING / BLSR system with respect to the SDH / SONET virtual containers carrying the data Ethernet packets, while ensuring that the standardized use of byte J1 is prevented with respect to the same SDH / SONET virtual containers carrying the Ethernet packets.

An implantable neurostimulator-implemented method for managing tachyarrhythmias through vagus nerve stimulation is provided. An implantable neurostimulator, including a pulse generator, is configured to deliver electrical therapeutic stimulation in a manner that results in creation and propagation (in both afferent and efferent directions) of action potentials within neuronal fibers of a patient's cervical vagus nerve. Operating modes of the pulse generator are stored. A maintenance dose of the electrical therapeutic stimulation is delivered to the vagus nerve via the pulse generator to restore cardiac autonomic balance through continuously-cycling, intermittent and periodic electrical pulses. A restorative dose of the electrical therapeutic stimulation is delivered to prevent initiation of or disrupt tachyarrhythmia through periodic electrical pulses delivered at higher intensity than the maintenance dose. The patient's normative physiology is monitored via a physiological sensor, and upon sensing a condition indicative of tachyarrhythmia, is switched to delivering the restorative dose to the vagus nerve.

An initiator including a housing adapted to be received in an igniter or rocket motor, at least one charge at a distal end of the housing, an electro-explosive device behind the charge for detonating the charge when subject to a voltage HV, and a pressure bulkhead behind the electro-explosive device. An electronic subsystem in the housing is connected to the electro-explosive device through the bulkhead and includes a lead for providing the voltage HV to the electro-explosive device to initiate it, and a switch in the lead which does not conduct if errant voltages are present on the lead to prevent initiation of the electro-explosive device until the correct voltage HV is present.

The invention provides methods for treating inflammatory diseases by administering to the subject an effective amount of an amyloid beta peptide, where the dose is effective to suppress or prevent initiation, progression, or relapses of disease, including the progression of established disease.

A portable communication device (10) is equipped with keypad filter circuitry (38), which is operable to eliminate or otherwise minimize calls, such as emergency calls and non-emergency calls, due to accidental or unintentional key press sequences. The keypad filter circuitry (38) receives (100) keypad input, analyzes (105) the received keypad input and determines (110) if the keypad input is accidental or unintentional. If the keypad input is determined to be accidental or unintentional, the portable communication device takes action to prevent initiation of the call and / or unlocking of the keypad.

The invention provides methods for treating inflammatory diseases by administering to the subject an effective amount of an agent that provides alpha B-crystallin activity, where the dose is effective to suppress or prevent initiation, progression, or relapses of disease, including the progression of established disease. In some embodiments, the methods of the invention comprise administering to a subject having a pre-existing inflammatory disease condition, an effective amount of alpha B-crystallin protein, to suppress or prevent relapses of the disease.